about
A Norse Contribution to the History of Neurological DiseasesHigh-throughput sequencing of immune repertoires in multiple sclerosisThe immunological basis for treatment of stiff person syndromeAlpha-tocopherol and MRI outcomes in multiple sclerosis--association and predictionA one year follow-up study of natural killer and dendritic cells activities in multiple sclerosis patients receiving glatiramer acetate (GA)Medicine and the arts. Three Elling Solheim poems translated by Alison Arderne Philip. Commentary.Month of birth and risk of multiple sclerosis: confounding and adjustmentsBone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study.Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activityHigh-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells.Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis: A Qualitative Study.Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis.Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case reportBone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study.Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trialListeria monocytogenes infection associated with alemtuzumab - - a case for better preventive strategies.Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.No association of tobacco use and disease activity in multiple sclerosisMultiple sclerosis: immunopathogenesis and controversies in defining the cause.Genetic and molecular approaches to the immunopathogenesis of multiple sclerosis: an update.Vitamin D in the healthy and inflamed central nervous system: access and function.Vitamin D in multiple sclerosis: implications for assessment and treatment.An update on cladribine for relapsing-remitting multiple sclerosis.Family planning, pregnancy and breastfeeding in multiple sclerosis.Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study.Mortality trends of amyotrophic lateral sclerosis in Norway 1951-2014: an age-period-cohort study.Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis.Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome.Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.Body mass index influence interferon-beta treatment response in multiple sclerosis.The EnvIMS Study: Design and Methodology of an International Case-Control Study of Environmental Risk Factors in Multiple Sclerosis.Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis.Medicine and the arts. Pesta on the Stairs by Theodor Kittelsen. Commentary.Unstable terminality: negotiating the meaning of chronicity and terminality in motor neurone disease.Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis.Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.In Silico Prediction Analysis of Idiotope-Driven T-B Cell Collaboration in Multiple Sclerosis.
P50
Q22241950-CC273902-E0ED-46EF-BB6C-7150E8AEDA97Q26747682-F6C991D7-5C4E-46FD-80E7-96D16FF89089Q28295552-D1CE376A-3B50-43DC-B842-5CF9FA934EABQ28485223-156337B7-A354-411E-A315-78A2A77AF6FFQ28486389-2EEFAD59-E476-4C00-9158-69550AB19750Q33435151-20803258-5BBB-49D5-B57B-F3B001889A24Q34418814-AAE55D67-622E-463D-A9A9-71A5CFB5A671Q34429852-4E199A41-762C-4C5B-8D1C-62DC4F82D367Q34999439-49945CFE-1808-4D6A-8B25-3638255C5701Q35221540-E13C6B74-AD7C-45BC-AF13-A1B978544077Q35683879-42AAC7FC-4DBC-4519-966C-7C94EC558A7EQ35843867-94659684-5EE3-4565-B5FA-7F5513A35101Q36166706-B3AB8150-E1A1-46E1-B6AC-E80572669831Q36213665-C5A5F803-FB53-42B7-B329-B4057FA9CA0CQ36311036-9749FDBC-65B1-44E7-B326-5D72C851F785Q36334659-BCFE0BF7-F8DD-454A-A175-33C3A9CB4AF3Q36334825-CD246166-EFE2-4CF1-9013-97D6753C0185Q36432956-3DFB4C59-4A38-4AD4-9ED4-BC141962EAF3Q37098475-B94D1E17-0777-4E50-8222-082DEABE5E20Q37151772-1F561E2F-2D9D-4B46-81C3-7A48964EDE24Q37550763-958347CE-8F56-42D2-8853-4C199719022DQ37921501-1C2E7E8C-7A10-4C99-9B48-FC824FF9701FQ38049627-6E343552-E771-4E94-BABF-DD51B8F10BA9Q38600051-7046C251-60AB-43F1-91E3-A056E0580AE5Q39004378-CF7A6768-069A-496B-97CB-5685471E7911Q39114204-68C6545C-9190-440B-AA11-7E272719DCB6Q39430589-0748A05E-BEE0-4BE2-8FCD-6725472C1815Q39454682-8A0BE331-BE87-4D9B-8CE0-273D185889E6Q39913279-86EDC485-7A89-4CBA-B38B-600984BF5F6FQ40529011-E9A2DCA5-3867-4C14-8B07-6EF494239EAAQ40924208-002D6D2E-636D-4D6B-A83A-9EBD3800D5EEQ40946896-1C200E53-B8D8-42F1-96CF-DF15BDFF02CFQ40969344-B39F4335-FB58-4D88-87D9-49D1829F444DQ41430215-16B32714-00AA-49E0-BE15-8775588D8984Q41445665-CF566580-69CD-418C-808E-082ADC6E9846Q41561147-9E7D5905-F3FE-4277-A24E-8E2365855653Q42217719-E7904F92-6625-47DF-ADC3-A01BAF3C9D4CQ42220189-00CE2D80-EF92-474D-BA8F-707043353A51Q42246326-CFB034FC-6EE4-4C1C-B8ED-B09A90D83463Q42371905-28FF6662-0A23-43B2-A858-88258B3AB0D7
P50
description
Noors onderzoeker
@nl
norsk professor
@nb
researcher
@en
taighdeoir
@ga
հետազոտող
@hy
name
Trygve Holmøy
@ast
Trygve Holmøy
@da
Trygve Holmøy
@de
Trygve Holmøy
@en
Trygve Holmøy
@es
Trygve Holmøy
@fr
Trygve Holmøy
@ga
Trygve Holmøy
@nb
Trygve Holmøy
@nl
Trygve Holmøy
@nn
type
label
Trygve Holmøy
@ast
Trygve Holmøy
@da
Trygve Holmøy
@de
Trygve Holmøy
@en
Trygve Holmøy
@es
Trygve Holmøy
@fr
Trygve Holmøy
@ga
Trygve Holmøy
@nb
Trygve Holmøy
@nl
Trygve Holmøy
@nn
prefLabel
Trygve Holmøy
@ast
Trygve Holmøy
@da
Trygve Holmøy
@de
Trygve Holmøy
@en
Trygve Holmøy
@es
Trygve Holmøy
@fr
Trygve Holmøy
@ga
Trygve Holmøy
@nb
Trygve Holmøy
@nl
Trygve Holmøy
@nn
P21
P27
P31
P496
0000-0002-2529-5664